ORBIMED ADVISORS LLC 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-24 5:44 pm Sale | 2025-07-22 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 132,473 4.250% | -111,405 (-45.68%) | Filing |
| 2025-07-21 5:28 pm Sale | 2025-07-17 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 243,878 7.820% | -52,299 (-17.66%) | Filing |
| 2025-07-09 8:06 pm Sale | 2025-07-07 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 296,177 9.500% | -36,323 (-10.92%) | Filing |
| 2025-04-25 7:48 pm Sale | 2025-04-22 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 332,500 10.700% | -37,743 (-10.19%) | Filing |
| 2024-12-26 4:31 pm Sale | 2024-12-20 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 370,243 12.000% | -31,457 (-7.83%) | Filing |
| 2024-04-12 5:35 pm Unchanged | 2024-04-09 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 401,700 13.000% | 0 (Unchanged) | Filing |
| 2023-06-29 4:36 pm Purchase | 2023-06-27 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 401,700 14.700% | 59,629 (+17.43%) | Filing |
| 2022-05-05 4:56 pm Purchase | 2022-05-03 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 342,071 12.600% | 44,705 (+15.03%) | Filing |
| 2021-01-28 1:48 pm Unchanged | 2021-01-26 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 297,366 11.200% | 0 (Unchanged) | Filing |